Literature DB >> 36157143

Alcohol and Acute-on-Chronic Liver Failure.

Maria Pilar Ballester1,2, Richard Sittner3, Rajiv Jalan4,5.   

Abstract

Acute-on-chronic liver failure (ACLF) is a clinical syndrome that occurs in patients with cirrhosis and is characterised by acute deterioration, organ failure and high short-term mortality. Alcohol is one of the leading causes of ACLF and the most frequently reported aetiology of underlying chronic liver disease. Among patients with alcoholic hepatitis (AH), ACLF is a frequent and severe complication. It is characterised by both immune dysfunction associated to an increased risk of infection and high-grade systemic inflammation that ultimately induce organ failure. Diagnosis and severity of ACLF determine AH prognosis, and therefore, ACLF prognostic scores should be used in severe AH with organ failure. Corticosteroids remain the first-line treatment for severe AH but they seem insufficient when ACLF is associated. Novel therapeutic targets to contain the excessive inflammatory response and reduce infection have been identified and are under investigation. With liver transplantation remaining one of the most effective therapies for severe AH and ACLF, adequate organ allocation represents a growing challenge. Hence, a clear understanding of the pathophysiology, clinical implications and management strategies of ACLF in AH is essential for hepatologists, which is narrated briefly in this review.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF, Acute-on-chronic liver failure; AH, alcoholic hepatitis; ALT, alanine aminotransferase; APASL, Asian Pacific Association for the Study of the Liver; AST, aspartate aminotransferase; DAMPs, damage-associated molecular patterns; EASL-CLIF, European Association for the Study of the Liver – Chronic Liver Failure Consortium; GAHS, Glasgow alcoholic hepatitis score; IL, interleukin; INR, international normalised ratio; MELD, model for end-stage liver disease; NAC, N-acetylcysteine; NACSELD, North American Consortium for the Study of End-Stage Liver Disease; PAMPs, pathogen-associated molecular patterns; TNF, tumour necrosis factor; WGO, World Gastroenterology Organization; acute-on-chronic liver failure; alcoholic hepatitis; cirrhosis

Year:  2021        PMID: 36157143      PMCID: PMC9499845          DOI: 10.1016/j.jceh.2021.12.010

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  94 in total

1.  A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure.

Authors:  Y-J Cai; J-J Dong; J-Z Dong; Y Chen; Z Lin; M Song; Y-Q Wang; Y-P Chen; K-Q Shi; M-T Zhou
Journal:  Aliment Pharmacol Ther       Date:  2017-03-26       Impact factor: 8.171

Review 2.  Treatment of severe alcoholic hepatitis: A systematic review.

Authors:  Lukas Van Melkebeke; Hannelie Korf; Emmanuel A Tsochatzis; Schalk van der Merwe; Frederik Nevens; Jef Verbeek
Journal:  Curr Opin Pharmacol       Date:  2021-08-05       Impact factor: 5.547

3.  TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.

Authors:  Naoko Matsunaga; Noboru Tsuchimori; Tatsumi Matsumoto; Masayuki Ii
Journal:  Mol Pharmacol       Date:  2010-09-29       Impact factor: 4.436

4.  Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.

Authors:  Richard Moreau; Laure Elkrief; Christophe Bureau; Jean-Marc Perarnau; Thierry Thévenot; Faouzi Saliba; Alexandre Louvet; Pierre Nahon; Adrien Lannes; Rodolphe Anty; Sophie Hillaire; Blandine Pasquet; Violaine Ozenne; Marika Rudler; Isabelle Ollivier-Hourmand; Marie Angèle Robic; Louis d'Alteroche; Vincent Di Martino; Marie-Pierre Ripault; Arnaud Pauwels; Jean-Didier Grangé; Nicolas Carbonell; Jean-Pierre Bronowicki; Audrey Payancé; Pierre-Emmanuel Rautou; Dominique Valla; Nathalie Gault; Didier Lebrec
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

5.  Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

Authors:  A Choudhury; A Jindal; R Maiwall; M K Sharma; B C Sharma; V Pamecha; M Mahtab; S Rahman; Y K Chawla; S Taneja; S S Tan; H Devarbhavi; Z Duan; Chen Yu; Q Ning; Ji Dong Jia; D Amarapurkar; C E Eapen; A Goel; S S Hamid; A S Butt; W Jafri; D J Kim; H Ghazinian; G H Lee; Ajit Sood; L A Lesmana; Z Abbas; G Shiha; D A Payawal; A K Dokmeci; J D Sollano; G Carpio; G K Lau; F Karim; P N Rao; R Moreau; P Jain; P Bhatia; G Kumar; S K Sarin
Journal:  Hepatol Int       Date:  2017-08-30       Impact factor: 6.047

6.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

7.  The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.

Authors:  Jonel Trebicka; Javier Fernandez; Maria Papp; Paolo Caraceni; Wim Laleman; Carmine Gambino; Ilaria Giovo; Frank Erhard Uschner; Cesar Jimenez; Rajeshwar Mookerjee; Thierry Gustot; Agustin Albillos; Rafael Bañares; Martin Janicko; Christian Steib; Thomas Reiberger; Juan Acevedo; Pietro Gatti; William Bernal; Stefan Zeuzem; Alexander Zipprich; Salvatore Piano; Thomas Berg; Tony Bruns; Flemming Bendtsen; Minneke Coenraad; Manuela Merli; Rudolf Stauber; Heinz Zoller; José Presa Ramos; Cristina Solè; Germán Soriano; Andrea de Gottardi; Henning Gronbaek; Faouzi Saliba; Christian Trautwein; Osman Cavit Özdogan; Sven Francque; Stephen Ryder; Pierre Nahon; Manuel Romero-Gomez; Hans Van Vlierberghe; Claire Francoz; Michael Manns; Elisabet Garcia; Manuel Tufoni; Alex Amoros; Marco Pavesi; Cristina Sanchez; Anna Curto; Carla Pitarch; Antonella Putignano; Esau Moreno; Debbie Shawcross; Ferran Aguilar; Joan Clària; Paola Ponzo; Christian Jansen; Zsuzsanna Vitalis; Giacomo Zaccherini; Boglarka Balogh; Victor Vargas; Sara Montagnese; Carlo Alessandria; Mauro Bernardi; Pere Ginès; Rajiv Jalan; Richard Moreau; Paolo Angeli; Vicente Arroyo
Journal:  J Hepatol       Date:  2020-07-13       Impact factor: 25.083

Review 8.  Treatment of Severe Alcoholic Hepatitis.

Authors:  Mark Thursz; Timothy R Morgan
Journal:  Gastroenterology       Date:  2016-03-04       Impact factor: 22.682

9.  Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.

Authors:  Xiaogang Xiang; Dechun Feng; Seonghwan Hwang; Tianyi Ren; Xiaolin Wang; Eszter Trojnar; Csaba Matyas; Ruidong Mo; Dabao Shang; Yong He; Wonhyo Seo; Vijay H Shah; Pal Pacher; Qing Xie; Bin Gao
Journal:  J Hepatol       Date:  2019-11-29       Impact factor: 25.083

10.  Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.

Authors:  Ruben Hernaez; Jennifer R Kramer; Yan Liu; Aylin Tansel; Yamini Natarajan; Khozema B Hussain; Pere Ginès; Elsa Solà; Richard Moreau; Alexander Gerbes; Hashem B El-Serag; Fasiha Kanwal
Journal:  J Hepatol       Date:  2018-12-25       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.